Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.

European journal of neurology2011Popat RA, Van Den Eeden SK, Tanner CM, et al.

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2011
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AgedCaffeineCase-Control StudiesCohort StudiesCytochrome P-450 CYP1A2FemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedNeuroprotective AgentsParkinson DiseasePhosphodiesterase InhibitorsReceptor, Adenosine A2A

DOI 10.1111/j.1468-1331.2011.03353.x

PMID 21281405

View source →